725 related articles for article (PubMed ID: 29723529)
1. Suppression of Elp2 prevents renal fibrosis and inflammation induced by unilateral ureter obstruction (UUO) via inactivating Stat3-regulated TGF-β1 and NF-κB pathways.
Lu S; Fan HW; Li K; Fan XD
Biochem Biophys Res Commun; 2018 Jun; 501(2):400-407. PubMed ID: 29723529
[TBL] [Abstract][Full Text] [Related]
2. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
3. Apamin inhibits renal fibrosis via suppressing TGF-β1 and STAT3 signaling in vivo and in vitro.
Gwon MG; An HJ; Gu H; Kim YA; Han SM; Park KK
J Mol Med (Berl); 2021 Sep; 99(9):1265-1277. PubMed ID: 34031696
[TBL] [Abstract][Full Text] [Related]
4. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
[TBL] [Abstract][Full Text] [Related]
5. Loss of poly(ADP-ribose) polymerase 1 attenuates renal fibrosis and inflammation during unilateral ureteral obstruction.
Kim J; Padanilam BJ
Am J Physiol Renal Physiol; 2011 Aug; 301(2):F450-9. PubMed ID: 21613422
[TBL] [Abstract][Full Text] [Related]
6. Suppression of TRPM2 reduces renal fibrosis and inflammation through blocking TGF-β1-regulated JNK activation.
Wang Y; Chen L; Wang K; Da Y; Zhou M; Yan H; Zheng D; Zhong S; Cai S; Zhu H; Li Y
Biomed Pharmacother; 2019 Dec; 120():109556. PubMed ID: 31655312
[TBL] [Abstract][Full Text] [Related]
7. ClC-5 alleviates renal fibrosis in unilateral ureteral obstruction mice.
Yang SX; Zhang ZC; Bai HL
Hum Cell; 2019 Jul; 32(3):297-305. PubMed ID: 31054069
[TBL] [Abstract][Full Text] [Related]
8. N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal inflammation and tubulointerstitial fibrosis in rats.
Wang M; Liu R; Jia X; Mu S; Xie R
Int J Mol Med; 2010 Dec; 26(6):795-801. PubMed ID: 21042772
[TBL] [Abstract][Full Text] [Related]
9. Nifuroxazide suppresses UUO-induced renal fibrosis in rats via inhibiting STAT-3/NF-κB signaling, oxidative stress and inflammation.
Hassan NME; Said E; Shehatou GSG
Life Sci; 2021 May; 272():119241. PubMed ID: 33600861
[TBL] [Abstract][Full Text] [Related]
10. Thioredoxin-interacting protein deficiency ameliorates kidney inflammation and fibrosis in mice with unilateral ureteral obstruction.
Wu M; Li R; Hou Y; Song S; Han W; Chen N; Du Y; Ren Y; Shi Y
Lab Invest; 2018 Sep; 98(9):1211-1224. PubMed ID: 29884908
[TBL] [Abstract][Full Text] [Related]
11. Protease-activated receptor 2 does not contribute to renal inflammation or fibrosis in the obstructed kidney.
Ma FY; Han Y; Ozols E; Chew P; Vesey DA; Gobe GC; Morais C; Lohman RJ; Suen JY; Johnson DW; Fairlie DP; Nikolic-Paterson DJ
Nephrology (Carlton); 2019 Sep; 24(9):983-991. PubMed ID: 31314137
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-26a-5p Restoration Ameliorates Unilateral Ureteral Obstruction-Induced Renal Fibrosis in Mice Through Modulating TGF-β Signaling.
Chung YH; Huang GK; Kang CH; Cheng YT; Kao YH; Chien YS
Lab Invest; 2023 Jul; 103(7):100131. PubMed ID: 36948295
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the short endoglin isoform reduces renal fibrosis and inflammation after unilateral ureteral obstruction.
Muñoz-Félix JM; Pérez-Roque L; Núñez-Gómez E; Oujo B; Arévalo M; Ruiz-Remolina L; Cuesta C; Langa C; Pérez-Barriocanal F; Bernabeu C; Lopez-Novoa JM
Biochim Biophys Acta; 2016 Sep; 1862(9):1801-14. PubMed ID: 27321931
[TBL] [Abstract][Full Text] [Related]
14. Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice.
Chung AC; Huang XR; Zhou L; Heuchel R; Lai KN; Lan HY
Nephrol Dial Transplant; 2009 May; 24(5):1443-54. PubMed ID: 19096081
[TBL] [Abstract][Full Text] [Related]
15. Dasatinib mitigates renal fibrosis in a rat model of UUO via inhibition of Src/STAT-3/NF-κB signaling.
Hassan NME; Shehatou GSG; Kenawy HI; Said E
Environ Toxicol Pharmacol; 2021 May; 84():103625. PubMed ID: 33617955
[TBL] [Abstract][Full Text] [Related]
16. Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy.
Liu Z; Huang XR; Chen HY; Penninger JM; Lan HY
Lab Invest; 2012 May; 92(5):650-61. PubMed ID: 22330342
[TBL] [Abstract][Full Text] [Related]
17. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
[TBL] [Abstract][Full Text] [Related]
18. Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy.
Guo G; Morrissey J; McCracken R; Tolley T; Klahr S
Am J Physiol; 1999 Nov; 277(5):F766-72. PubMed ID: 10564241
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway.
Kim D; Lee AS; Jung YJ; Yang KH; Lee S; Park SK; Kim W; Kang KP
Nephrol Dial Transplant; 2014 Nov; 29(11):2043-53. PubMed ID: 25031017
[TBL] [Abstract][Full Text] [Related]
20. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.
Li YK; Ma DX; Wang ZM; Hu XF; Li SL; Tian HZ; Wang MJ; Shu YW; Yang J
Pharmacol Res; 2018 May; 131():102-111. PubMed ID: 29530599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
